Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SINT vs AHCO vs MDT vs HOLX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SINT
Sintx Technologies, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$9M
5Y Perf.-100.0%
AHCO
AdaptHealth Corp.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$1.54B
5Y Perf.-30.2%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$97.62B
5Y Perf.-22.8%
HOLX
Hologic, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$16.97B
5Y Perf.+42.6%

SINT vs AHCO vs MDT vs HOLX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SINT logoSINT
AHCO logoAHCO
MDT logoMDT
HOLX logoHOLX
IndustryMedical - DevicesMedical - DevicesMedical - DevicesMedical - Instruments & Supplies
Market Cap$9M$1.54B$97.62B$16.97B
Revenue (TTM)$1M$2.86B$35.48B$4.13B
Net Income (TTM)$-17M$-80M$4.61B$544M
Gross Margin50.0%1.8%61.9%52.8%
Operating Margin-8.3%7.2%17.9%17.5%
Forward P/E12.6x13.8x17.2x
Total Debt$3M$1.90B$28.52B$2.63B
Cash & Equiv.$4M$106M$2.22B$1.96B

SINT vs AHCO vs MDT vs HOLXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SINT
AHCO
MDT
HOLX
StockMay 20May 26Return
Sintx Technologies,… (SINT)1000.0-100.0%
AdaptHealth Corp. (AHCO)10069.8-30.2%
Medtronic plc (MDT)10077.2-22.8%
Hologic, Inc. (HOLX)100142.6+42.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: SINT vs AHCO vs MDT vs HOLX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Hologic, Inc. is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. AHCO also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
SINT
Sintx Technologies, Inc.
The Secondary Option

SINT lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
AHCO
AdaptHealth Corp.
The Value Play

AHCO is the clearest fit if your priority is value.

  • Lower P/E (12.6x vs 17.2x)
Best for: value
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 36 yrs, beta 0.42, yield 3.7%
  • Rev growth 3.6%, EPS growth 30.8%, 3Y rev CAGR 1.9%
  • Lower volatility, beta 0.42, Low D/E 59.1%, current ratio 1.85x
  • Beta 0.42, yield 3.7%, current ratio 1.85x
Best for: income & stability and growth exposure
HOLX
Hologic, Inc.
The Long-Run Compounder

HOLX is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 124.3% 10Y total return vs MDT's 24.3%
  • 13.2% margin vs SINT's -13.6%
  • +35.3% vs MDT's -5.5%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthMDT logoMDT3.6% revenue growth vs SINT's -18.3%
ValueAHCO logoAHCOLower P/E (12.6x vs 17.2x)
Quality / MarginsHOLX logoHOLX13.2% margin vs SINT's -13.6%
Stability / SafetyMDT logoMDTBeta 0.42 vs SINT's 1.94, lower leverage
DividendsMDT logoMDT3.7% yield; 36-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)HOLX logoHOLX+35.3% vs MDT's -5.5%
Efficiency (ROA)MDT logoMDT175.8% ROA vs SINT's -159.9%, ROIC 6.0% vs -253.2%

SINT vs AHCO vs MDT vs HOLX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SINTSintx Technologies, Inc.
FY 2024
Grant and Contract
56.8%$2M
Product
43.2%$1M
AHCOAdaptHealth Corp.
FY 2025
Respiratory Health
100.0%$691M
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B
HOLXHologic, Inc.
FY 2025
Diagnostics
44.6%$1.8B
Breast Health
36.2%$1.5B
Gyn Surgical
16.6%$680M
Skeletal Health
2.7%$109M

SINT vs AHCO vs MDT vs HOLX — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHOLXLAGGINGSINT

Income & Cash Flow (Last 12 Months)

Evenly matched — MDT and HOLX each lead in 2 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 29109.1x SINT's $1M. HOLX is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to SINT's -13.6%. On growth, AHCO holds the edge at +41.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSINT logoSINTSintx Technologie…AHCO logoAHCOAdaptHealth Corp.MDT logoMDTMedtronic plcHOLX logoHOLXHologic, Inc.
RevenueTrailing 12 months$1M$2.9B$35.5B$4.1B
EBITDAEarnings before interest/tax-$9M$504M$9.4B$974M
Net IncomeAfter-tax profit-$17M-$80M$4.6B$544M
Free Cash FlowCash after capex-$8M$219M$5.4B$1000M
Gross MarginGross profit ÷ Revenue+50.0%+1.8%+61.9%+52.8%
Operating MarginEBIT ÷ Revenue-8.3%+7.2%+17.9%+17.5%
Net MarginNet income ÷ Revenue-13.6%-2.8%+13.0%+13.2%
FCF MarginFCF ÷ Revenue-6.3%+7.7%+15.2%+24.2%
Rev. Growth (YoY)Latest quarter vs prior year-43.3%+41.2%+8.8%+2.5%
EPS Growth (YoY)Latest quarter vs prior year+50.2%-140.0%-11.9%-9.2%
Evenly matched — MDT and HOLX each lead in 2 of 6 comparable metrics.

Valuation Metrics

AHCO leads this category, winning 6 of 6 comparable metrics.

At 21.1x trailing earnings, MDT trades at a 31% valuation discount to HOLX's 30.5x P/E. On an enterprise value basis, AHCO's 5.6x EV/EBITDA is more attractive than HOLX's 17.4x.

MetricSINT logoSINTSintx Technologie…AHCO logoAHCOAdaptHealth Corp.MDT logoMDTMedtronic plcHOLX logoHOLXHologic, Inc.
Market CapShares × price$9M$1.5B$97.6B$17.0B
Enterprise ValueMkt cap + debt − cash$8M$3.3B$123.9B$17.6B
Trailing P/EPrice ÷ TTM EPS-0.39x-21.73x21.09x30.53x
Forward P/EPrice ÷ next-FY EPS est.12.61x13.80x17.21x
PEG RatioP/E ÷ EPS growth rate35.17x
EV / EBITDAEnterprise value multiple5.56x14.06x17.39x
Price / SalesMarket cap ÷ Revenue8.52x0.47x2.91x4.14x
Price / BookPrice ÷ Book value/share2.27x1.00x2.04x3.43x
Price / FCFMarket cap ÷ FCF7.00x18.83x18.44x
AHCO leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

HOLX leads this category, winning 5 of 9 comparable metrics.

HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-4 for SINT. HOLX carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to AHCO's 1.25x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs SINT's 3/9, reflecting strong financial health.

MetricSINT logoSINTSintx Technologie…AHCO logoAHCOAdaptHealth Corp.MDT logoMDTMedtronic plcHOLX logoHOLXHologic, Inc.
ROE (TTM)Return on equity-3.7%-5.1%+9.4%+11.0%
ROA (TTM)Return on assets-159.9%-1.8%+175.8%+6.1%
ROICReturn on invested capital-2.5%+4.0%+6.0%+9.4%
ROCEReturn on capital employed-162.4%+5.0%+7.5%+8.8%
Piotroski ScoreFundamental quality 0–93567
Debt / EquityFinancial leverage1.11x1.25x0.59x0.52x
Net DebtTotal debt minus cash-$898,000$1.8B$26.3B$667M
Cash & Equiv.Liquid assets$4M$106M$2.2B$2.0B
Total DebtShort + long-term debt$3M$1.9B$28.5B$2.6B
Interest CoverageEBIT ÷ Interest expense-181.30x0.65x9.08x8.00x
HOLX leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HOLX leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in HOLX five years ago would be worth $11,678 today (with dividends reinvested), compared to $1 for SINT. Over the past 12 months, HOLX leads with a +35.3% total return vs MDT's -5.5%. The 3-year compound annual growth rate (CAGR) favors MDT at -2.1% vs SINT's -79.9% — a key indicator of consistent wealth creation.

MetricSINT logoSINTSintx Technologie…AHCO logoAHCOAdaptHealth Corp.MDT logoMDTMedtronic plcHOLX logoHOLXHologic, Inc.
YTD ReturnYear-to-date-36.5%+16.9%-20.0%+1.9%
1-Year ReturnPast 12 months-5.1%+34.8%-5.5%+35.3%
3-Year ReturnCumulative with dividends-99.2%-6.4%-6.3%-8.5%
5-Year ReturnCumulative with dividends-100.0%-54.7%-29.2%+16.8%
10-Year ReturnCumulative with dividends-100.0%+16.5%+24.3%+124.3%
CAGR (3Y)Annualised 3-year return-79.9%-2.2%-2.1%-2.9%
HOLX leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MDT and HOLX each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than SINT's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs SINT's 35.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSINT logoSINTSintx Technologie…AHCO logoAHCOAdaptHealth Corp.MDT logoMDTMedtronic plcHOLX logoHOLXHologic, Inc.
Beta (5Y)Sensitivity to S&P 5001.94x0.72x0.42x0.45x
52-Week HighHighest price in past year$6.78$13.43$106.33$76.04
52-Week LowLowest price in past year$1.99$8.06$75.91$53.62
% of 52W HighCurrent price vs 52-week peak+35.4%+84.1%+71.6%+100.0%
RSI (14)Momentum oscillator 0–10045.743.429.269.1
Avg Volume (50D)Average daily shares traded37K1.4M7.9M10.3M
Evenly matched — MDT and HOLX each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 1 of 1 comparable metric.

Analyst consensus: AHCO as "Buy", MDT as "Buy", HOLX as "Hold". Consensus price targets imply 43.8% upside for MDT (target: $110) vs 3.9% for HOLX (target: $79). MDT is the only dividend payer here at 3.65% yield — a key consideration for income-focused portfolios.

MetricSINT logoSINTSintx Technologie…AHCO logoAHCOAdaptHealth Corp.MDT logoMDTMedtronic plcHOLX logoHOLXHologic, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$14.00$109.50$79.00
# AnalystsCovering analysts124942
Dividend YieldAnnual dividend ÷ price+3.7%
Dividend StreakConsecutive years of raises1136
Dividend / ShareAnnual DPS$2.78
Buyback YieldShare repurchases ÷ mkt cap+1.5%0.0%+3.3%+4.4%
MDT leads this category, winning 1 of 1 comparable metric.
Key Takeaway

HOLX leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). AHCO leads in 1 (Valuation Metrics). 2 tied.

Best OverallHologic, Inc. (HOLX)Leads 2 of 6 categories
Loading custom metrics...

SINT vs AHCO vs MDT vs HOLX: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SINT or AHCO or MDT or HOLX a better buy right now?

For growth investors, Medtronic plc (MDT) is the stronger pick with 3.

6% revenue growth year-over-year, versus -18. 3% for Sintx Technologies, Inc. (SINT). Medtronic plc (MDT) offers the better valuation at 21. 1x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate AdaptHealth Corp. (AHCO) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SINT or AHCO or MDT or HOLX?

On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.

1x versus Hologic, Inc. at 30. 5x. On forward P/E, AdaptHealth Corp. is actually cheaper at 12. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — SINT or AHCO or MDT or HOLX?

Over the past 5 years, Hologic, Inc.

(HOLX) delivered a total return of +16. 8%, compared to -100. 0% for Sintx Technologies, Inc. (SINT). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus SINT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SINT or AHCO or MDT or HOLX?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

42β versus Sintx Technologies, Inc. 's 1. 94β — meaning SINT is approximately 357% more volatile than MDT relative to the S&P 500. On balance sheet safety, Hologic, Inc. (HOLX) carries a lower debt/equity ratio of 52% versus 125% for AdaptHealth Corp. — giving it more financial flexibility in a downturn.

05

Which is growing faster — SINT or AHCO or MDT or HOLX?

By revenue growth (latest reported year), Medtronic plc (MDT) is pulling ahead at 3.

6% versus -18. 3% for Sintx Technologies, Inc. (SINT). On earnings-per-share growth, the picture is similar: Sintx Technologies, Inc. grew EPS 59. 4% year-over-year, compared to -185. 2% for AdaptHealth Corp.. Over a 3-year CAGR, SINT leads at 19. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SINT or AHCO or MDT or HOLX?

Medtronic plc (MDT) is the more profitable company, earning 13.

9% net margin versus -1678. 1% for Sintx Technologies, Inc. — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MDT leads at 17. 8% versus -1053. 1% for SINT. At the gross margin level — before operating expenses — MDT leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SINT or AHCO or MDT or HOLX more undervalued right now?

On forward earnings alone, AdaptHealth Corp.

(AHCO) trades at 12. 6x forward P/E versus 17. 2x for Hologic, Inc. — 4. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 43. 8% to $109. 50.

08

Which pays a better dividend — SINT or AHCO or MDT or HOLX?

In this comparison, MDT (3.

7% yield) pays a dividend. SINT, AHCO, HOLX do not pay a meaningful dividend and should not be held primarily for income.

09

Is SINT or AHCO or MDT or HOLX better for a retirement portfolio?

For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

42), 3. 7% yield). Sintx Technologies, Inc. (SINT) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MDT: +24. 3%, SINT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SINT and AHCO and MDT and HOLX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SINT is a small-cap quality compounder stock; AHCO is a small-cap quality compounder stock; MDT is a mid-cap income-oriented stock; HOLX is a mid-cap quality compounder stock. MDT pays a dividend while SINT, AHCO, HOLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SINT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 30%
Run This Screen
Stocks Like

AHCO

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 20%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

HOLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SINT and AHCO and MDT and HOLX on the metrics below

Revenue Growth>
%
(SINT: -43.3% · AHCO: 41.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.